ask="14.00"
ask_size="100"
average_daily_volume="29497"
bid="N/A"
bid_size="N/A"
book_value="3.34"
change="+0.34"
change_from_200_day_moving_average="4.74"
change_from_50_day_moving_average="1.91"
change_from_52_week_high="-0.90"
change_From_52_week_low="8.33"
change_in_percent="+2.95%"
close="11.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.09"
ebitda="-50.28M"
eps_estimate_current_year="-2.53"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="11.99"
high_52_weeks="12.75"
last_trade_date="3/13/2017"
last_trade_price="11.85"
last_trade_size="127"
last_trade_time="3:59pm"
low="11.65"
low_52_weeks="3.52"
market_capitalization="252.17M"
moving_average_200_day="7.11"
moving_average_50_day="9.94"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.82"
open="11.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+66.60%"
percent_change_from_50_day_moving_average="+19.24%"
percent_change_from_52_week_high="-7.06%"
percent_change_from_52_week_low="+236.65%"
previous_close="11.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.45"
price_per_sales="47.10"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.35"
stock_exchange="NMS"
symbol="NBRV"
volume="18972"
weeks_range_52="3.52 - 12.75"
